Cat. #161134
UOL-HepCYB11 cell line
Cat. #: 161134
Availability: 8-10 weeks
Organism: Human
Tissue: Liver
Disease: Mitochondrial Subhaplogroup : J1c1c
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Amy Chadwick
Institute: University of Liverpool, Molecular and Clinical Pharmacology
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: UOL-HepCYB11 cell line
- Research fields: Drug development
- Parental cell: HepG2
- Organism: Human
- Tissue: Liver
- Disease: Mitochondrial Subhaplogroup : J1c1c
- Growth properties: Adherent
- Model description: Cybrid Cell Line
- Description: This cell line consists of HepG2 cybrid cell lines negative for cellular mitochondrial DNA, fused with different platelet partners (platelets contain only mitochondrial DNA and no nuclear DNA). Each cybrid cell line has a combination of SNPs in mitochondrial DNA, relevant to a variety of diseases. Cybrid cell line panel has potential use for drug testing
- Additional notes: Parental cell line was purchased from ECACC
Applications
- Application notes: SNPs characteristic of assigned haplogroup : 185A 228A 462T 482C 489C 750G 1438G 3010A 3394C 4216C 4769G 7028T 8860G 10398G 11251G 11719A 13708A 14766T 14798C 15326G 15452A 16069T 16126C 16145A Additional SNPs : 188G 13943T 14552G
Handling
- Growth medium: DMEM high-glucose medium (glucose; 25?mM) supplemented with FBS (10 % v/v), L-glutamine (4?mM), sodium pyruvate (1?mM), and HEPES (1?mM)
- Temperature: 37° C
- Atmosphere: 5% CO2
- Subculture routine: Cells are subcultured weekly (1:12) via trypsinisation.
